Inkaum Biomed Private Limited
Founded in 2012 and headquartered in Uttar Pradesh, India.
2012 | Lucknow, Uttar Pradesh (India) | Active
Inkaum Biomed Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 13 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth -269.03%
- Ebitda -161.07%
- Net Worth -30.69%
- Total Assets -24.13%
About Inkaum Biomed
Inkaum Biomed Private Limited (IBPL) is a Private Limited Indian Non-Government Company incorporated in India on 05 January 2012 and has a history of 13 years and one month. Its registered office is in Lucknow, Uttar Pradesh, India.
The Corporate was formerly known as Sun Staffing Solutions Private Limited. The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Avinash Tripathi and Madhulika Tripathi serve as directors at the Company.
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74120UP2012PTC048224
- Company No.
048224
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Jan 2012
- Date of AGM
21 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Business Services
Who are the key members and board of directors at Inkaum Biomed?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Avinash Tripathi  | Director | 04-Aug-2020 | Current |
| Madhulika Tripathi | Director | 05-Jan-2012 | Current |
Financial Performance of Inkaum Biomed.
Inkaum Biomed Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 269.03% decrease in profit. The company's net worth observed a substantial decline by a decrease of 30.69%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Inkaum Biomed?
In 2017, Inkaum Biomed had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- T & T Technologies Private Limited
Avinash Tripathi and Madhulika Tripathi are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Inkaum Biomed?
Unlock and access historical data on people associated with Inkaum Biomed, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Inkaum Biomed, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Inkaum Biomed's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
